Do All Patients Need β-Blockers After a Heart Attack?

JAMA. 2018 Mar 6;319(9):853-855. doi: 10.1001/jama.2018.0107.
No abstract available

Publication types

  • News

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / prevention & control
  • Observational Studies as Topic
  • Practice Guidelines as Topic
  • Secondary Prevention*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors